BIORA THERAPEUTICS INC - COM NEW (BIOR)

CUSIP: 74319F305

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / COM NEW
Total 13F shares
11,935,908
Share change
+8,495,119
Total reported value
$25,901,407
Put/Call ratio
0%
Price per share
$2.17
Number of holders
25
Value change
+$17,252,537
Number of buys
13
Number of sells
14

Quarterly Holders Quick Answers

What is CUSIP 74319F305?
CUSIP 74319F305 identifies BIOR - BIORA THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of BIORA THERAPEUTICS INC - COM NEW (BIOR) as of Q3 2023

As of 30 Sep 2023, BIORA THERAPEUTICS INC - COM NEW (BIOR) was held by 25 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 11,935,908 shares. The largest 10 holders included Athyrium Capital Management, LP, SABBY MANAGEMENT, LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., Schonfeld Strategic Advisors LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, STATE STREET CORP, LPL Financial LLC, and CIBC Asset Management Inc. This page lists 25 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.